Trump Psychedelics Order Sparks Buzz and Fears

President Trump's order to advance psychedelic treatments generates excitement for breakthrough mental health therapies alongside worries from skeptics. Proponents hail it as a bold step against Big Pharma monopolies and FDA foot-dragging on promising drugs like psilocybin for depression. This aligns with America First by fostering innovation and veteran care without globalist interference. Critics fret over risks, but Trump's push empowers personal choice over nanny-state bans. Read more about this...